United States Biotechnology & Medical Research

Translate Bio Inc (TBIO)

Track

Ticker: TBIO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 14 Sep 2021
Value US$2,614,885.76 | Price 428.26 | Shares 43,492 (+49.9%)
Sale 14 Sep 2021
Value US$2,835,434.58 | Price 391.90 | Shares 72,696 (-20.6%)
Sale 14 Sep 2021
Value US$19,122,778.00 | Price 38.00 | Shares 503,231 (-100.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-09-14 2021-09-14 S Sale
2.7
Renaud Ronald C JR

Chief Executive Officer

Executive Director
43,492 +49.9%
428.26
US$2,614,886 		43,492 +49.9% 428.26 US$2,614,886
2021-09-14 2021-09-14 S Sale
2.7
Renaud Ronald C JR

Chief Executive Officer

Executive Director
72,696 -20.6%
391.90
US$2,835,435 		72,696 -20.6% 391.90 US$2,835,435
2021-09-14 2021-09-14 S Sale
2.7
Renaud Ronald C JR

Chief Executive Officer

Executive Director
91,599 +19.0%
345.95
US$4,093,125 		91,599 +19.0% 345.95 US$4,093,125
2021-09-14 2021-09-14 S Sale
3.0
Hughes Owen
Non-Executive Director
29,860 -100.0%
38.00
US$1,134,680 		29,860 -100.0% 38.00 US$1,134,680
2021-09-14 2021-09-14 PlS Planned sale
1.5
FORMELA JEAN FRANCOIS
Non-Executive Director
2,055,063 -100.0%
38.00
US$78,092,394 		2,055,063 -100.0% 38.00 US$78,092,394
2021-09-14 2021-09-14 B Purchase
2.4
Sanofi
Large shareholder
20,515,985 +37.2%
38.00
US$779,607,430 		20,515,985 +37.2% 38.00 US$779,607,430
2021-09-14 2021-09-14 B Purchase
2.4
Sanofi
Large shareholder
51,467,612 +1396.9%
38.00
US$1,955,769,256 		51,467,612 +1396.9% 38.00 US$1,955,769,256
2021-09-14 2021-09-14 S Sale
3.0
Burgess Paul D.

Chief Operating Officer, CLO

Officer
71,833 -100.0%
38.00
US$2,729,654 		71,833 -100.0% 38.00 US$2,729,654
2020-12-23 2020-12-22 PlS Planned sale
1.5
FORMELA JEAN FRANCOIS
Non-Executive Director
2,700 -5.8%
25.88
US$69,883 		2,700 -5.8% 25.88 US$69,883
2020-12-23 2020-12-22 PlS Planned sale
1.5
FORMELA JEAN FRANCOIS
Non-Executive Director
79,865 -63.1%
25.04
US$1,999,987 		79,865 -63.1% 25.04 US$1,999,987
2020-12-23 2020-12-21 PlS Planned sale
1.5
FORMELA JEAN FRANCOIS
Non-Executive Director
56,536 -30.9%
25.50
US$1,441,928 		56,536 -30.9% 25.50 US$1,441,928
2020-08-27 2020-08-27 S Sale
1.5
FORMELA JEAN FRANCOIS
Non-Executive Director
10,097 -0.3%
14.38
US$145,217 		10,097 -0.3% 14.38 US$145,217
2020-08-27 2020-08-26 S Sale
1.5
FORMELA JEAN FRANCOIS
Non-Executive Director
44,381 -1.1%
14.80
US$656,746 		44,381 -1.1% 14.80 US$656,746
2020-08-27 2020-08-25 S Sale
1.5
FORMELA JEAN FRANCOIS
Non-Executive Director
34,410 -0.9%
15.00
US$516,160 		34,410 -0.9% 15.00 US$516,160
2020-06-05 2020-06-03 S Sale
Shire Human Genetic Therapies, Inc.
Large shareholder
40,086 -0.6%
19.75
US$791,698 		40,086 -0.6% 19.75 US$791,698
2020-06-03 2020-06-02 S Sale
Shire Human Genetic Therapies, Inc.
Large shareholder
5,006 -0.1%
20.02
US$100,220 		5,006 -0.1% 20.02 US$100,220
2020-06-03 2020-06-02 S Sale
Shire Human Genetic Therapies, Inc.
Large shareholder
100,389 -1.4%
19.75
US$1,982,683 		100,389 -1.4% 19.75 US$1,982,683
2020-06-03 2020-06-01 S Sale
Shire Human Genetic Therapies, Inc.
Large shareholder
1,400 -0.0%
20.53
US$28,742 		1,400 -0.0% 20.53 US$28,742
2020-06-03 2020-06-01 S Sale
Shire Human Genetic Therapies, Inc.
Large shareholder
107,072 -1.5%
19.85
US$2,125,379 		107,072 -1.5% 19.85 US$2,125,379
2018-07-05 2018-07-02 B Purchase Gallagher Brian M. Jr. Non-Executive Director
269,230 +7.9%
13.00
US$3,499,990 		269,230 +7.9% 13.00 US$3,499,990
2018-07-03 2018-07-02 B Purchase MRL Ventures Fund LLC Large shareholder
25,000 +1.4%
13.00
US$325,000 		25,000 +1.4% 13.00 US$325,000
2018-07-03 2018-07-02 B Purchase GLAXOSMITHKLINE PLC Large shareholder
269,230 +7.9%
13.00
US$3,499,990 		269,230 +7.9% 13.00 US$3,499,990
Explore more

More insider trading research around Translate Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America